Sumitomo Chemical India Limited reported a 20.4% year-on-year increase in standalone net profit to ₹2,165.29 million for the quarter ended June 30, 2026 (Q1FY26), primarily driven by a one-time insurance claim. The agro-chemicals company’s consolidated net profit attributable to owners of the holding company rose 20.5% to ₹2,148.30 million, while revenue from operations grew marginally by 0.6% to ₹10,540.75 million on a standalone basis and remained flat at ₹10,633.46 million on a consolidated basis compared to the prior year period.

The Board of Directors approved the unaudited financial statements on July 27, 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were reviewed by the Audit Committee and subjected to a limited review by B S R & Co. LLP, the statutory auditors. The filing includes both standalone and consolidated financial results for the quarter, prepared in accordance with Indian Accounting Standards (Ind AS).

Key Financial Highlights

The following table presents the standalone and consolidated financial performance for Q1FY26:

On an operational efficiency front, consolidated EBITDA improved to ₹2.3 billion from ₹2.2 billion in the same quarter last year, with the EBITDA margin expanding to 22% from 20.74% year-on-year. Other income contributed ₹472.84 million to the consolidated total, up from ₹387.86 million in the prior year period. Total comprehensive income for the group stood at ₹2,135.28 million.

What the Numbers Show

The profit growth was significantly boosted by exceptional items rather than core operational expansion. The company recorded a ₹268.96 million gain from an insurance claim for business interruption due to a fire incident at its Bhavnagar plant during FY23. Excluding this one-time gain, the core operational profit before tax was ₹2,643.65 million (standalone), reflecting steady underlying performance. In contrast, the prior year saw a ₹151.86 million exceptional charge related to new labour codes, highlighting the volatility from regulatory and non-operational factors.

Regulatory risks remain a key focus for the agro-chemicals segment. A Central Government notification issued in October 2022 mandates that Glyphosate, a critical product, be used only through Pest Control Operators. Industry petitions challenging this notification are pending before the Delhi High Court, with the government stating implementation will be stayed until disposal. The company operates in a single reportable segment, making it susceptible to these regulatory shifts and climatic variations affecting demand. The consolidated results include two subsidiaries: Barrix Agro Sciences Private Limited and Excel Crop Care (Africa) Limited, which is under liquidation.

Sumitomo Chemical has accepted the resignation of Ninad D. Gupte as a Non-Executive, Non-Independent Director, effective August 31, 2026. The Mumbai-based chemical manufacturer disclosed the change in its Board composition on July 27, 2026, notifying both the Bombay Stock Exchange and the National Stock Exchange of India. The company stated that Mr. Gupte resigned for personal reasons and confirmed that there are no other material factors influencing his decision to step down.

The intimation was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para A of Part A of Schedule III to the said Regulations. The disclosure also aligns with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. Deepika Trivedi, Company Secretary & Compliance Officer, signed the communication on behalf of the company.

Resignation Details

Mr. Gupte, who holds DIN 00027523, tendered his resignation effective from the close of business hours on August 31, 2026. In his resignation letter addressed to the Chairman, he expressed gratitude for the cooperation received from fellow directors during his tenure and thanked the management of Sumitomo Chemical Company, Japan, for the opportunity to serve.

Other Directorships

The filing notes that Mr. Gupte continues to hold directorships in other listed entities. He serves as an Independent Director at Excel Industries Limited. At Excel Industries, he chairs the Nomination & Remuneration Committee and serves as a member of both the Audit Committee and the Risk Management Committee. These roles are distinct from his position at Sumitomo Chemical India Ltd.